EU-sikkerhedsovervågning

✅

Ingen aktive alarmer

Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.

Hvad det bruges til

Beyfortus is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in:i.        Neonates and infants during their first RSV season.ii.        Children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season (see section 5.1).Beyfortus should be used in accordance with official recommendations. Beyfortus is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in:i.          Neonates and infants during their first RSV season.ii.         Children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season (see section 5.1).Beyfortus should be used in accordance with official recommendations.

⚠️ Patient sikkerhed

No

Officiel EMA-side

https://www.ema.europa.eu/en/medicines/human/EPAR/beyfortus